|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/30 | (2006.01) |
| C07K 16/2818 | (2013.01) | ||
| A61K 31/4745 | (2006.01) | ||
| C07K 16/2827 | (2013.01) | ||
| A61K 31/708 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K 31/4375 | (2006.01) | ||
| A61K 47/6803 | (2017.08) | ||
| A61K 47/50 | (2017.01) | ||
| A61K 47/6851 | (2017.08) | ||
| A61K 45/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3763742 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20191420.7 |
| Europos patento paraiškos padavimo data | 2015-08-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-01-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-10-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201410440824 | 2014-09-01 | CN |
| (72) |
LI, Lixin , CN
LAU, Walter , CN
|
| (73) |
Birdie Biopharmaceuticals Inc. ,
Sertus Chambers
P.O. Box 2547
Cassia Court
Camana Bay, Grand Cayman,
KY
|
| (54) | ANTI-PD-L1 CONJUGATES FOR TREATING TUMORS |
| ANTI-PD-L1 CONJUGATES FOR TREATING TUMORS |